Harmony Biosciences Holdings (HRMY) Share-based Compensation (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Harmony Biosciences Holdings | 1.83 Bn | 1.19 Bn | 170.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.50% |
| Dec 31, 2025 | -9.09% |
| Sep 30, 2025 | -4.24% |
| Jun 30, 2025 | -8.35% |
| Mar 31, 2025 | 24.10% |
| Dec 31, 2024 | -12.02% |
| Sep 30, 2024 | 4.42% |
| Jun 30, 2024 | 5.47% |
| Mar 31, 2024 | 10.65% |
| Dec 31, 2023 | 18.06% |
| Sep 30, 2023 | 2.10% |
| Jun 30, 2023 | 18.78% |
| Mar 31, 2023 | -5.45% |
| Dec 31, 2022 | -0.40% |
| Sep 30, 2022 | -5.48% |
| Jun 30, 2022 | 59.27% |
| Mar 31, 2022 | 17.55% |
| Dec 31, 2021 | -15.59% |
| Sep 30, 2021 | 22.51% |
| Jun 30, 2021 | 17.10% |
| Mar 31, 2021 | 33.95% |
| Dec 31, 2020 | 82.48% |
| Sep 30, 2020 | 188.50% |
| Jun 30, 2020 | -2.95% |
| Mar 31, 2020 | -94.61% |
| Dec 31, 2019 | 2,063.39% |